The Future of Biotechnology Therapies

By StartUp City | Wednesday, October 07, 2020

Pharmacogenomics has already transformed the way clinical trials are done - genetic data is routinely collected that allows researchers to determine whether different responses to a test medicine could be explained by genetic factors. The information is kept anonymous in order to protect patients' privacy.

FREMONT, CA: Though biotechnology is still in its nascent phase, it possesses great potential for driving medical progress. The one-size-fits-all approach no longer applies to today's consumers who want everything tailor-made as per their needs. This is why much of medical progress is expected to result from advances in personalized medicine. This new treatment approach focuses on ensuring that patients get therapies best suited to their specific conditions.

Top 15 BioTech Startups - 2019For instance, a new discipline called pharmacogenomics aims to determine how a patient's genetic profile impacts their responses to particular medicines. The purpose is to develop tests that would predict which patient genetic profiles can benefit from a given medicine. This model is often called personalized medicine.

Pharmacogenomics has already transformed the way clinical trials are done - genetic data is routinely collected that allows researchers to determine whether different responses to a test medicine could be explained by genetic factors. The information is kept anonymous in order to protect patients' privacy.

Besides, biotechnology is carving a new path to the diagnosis of genetic diseases. New tests can identify changes in the DNA sequence of genes related to disease risk and can predict the probability that a patient will develop a disease. Early diagnosis is sometimes the only way to either preventing a disease or controlling disease progress through early treatment.

Let us look at some emerging treatments in biotechnology therapy:

Gene therapy

It involves inserting genes into a patient's cells in order to replace flawed genes with functional genes. The field is still in its exploratory stages but has grown dramatically since the first clinical trial in 1990.

Nanomedicine

It targets to manipulate structures and molecules on an atomic scale. One example is the experimental utilization of nanoshells, or metallic lenses, which convert infrared light into heat energy to kill cancer cells completely.

Stem cells

Stem cells are primitive cells that can mature into various types of functional cells. Stem cells can be made and grown in a lab, guided toward the required cell type and then surgically implanted into patients. The goal is to replace dead tissue with new, healthy tissue.

See Also: Top Genomics Solution Companies

Weekly Brief